Assignee profile:

BACH PHARMA, INC.

City:

North Andover, Massachusetts

Country:

United States

Published Applications:

11

Last publication date:

2016-08-18

Patent Grants:

7

Last grant date:

2017-08-15

Top Inventors for applications by BACH PHARMA, INC.

These are the the leading inventors for applications assigned to BACH PHARMA, INC.:

Recent patent applications by BACH PHARMA, INC.

BACH PHARMA, INC. based in North Andover, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-08-18 ✅ Patent 9,732,043 granted on 2017-08-15
US20160237039A1
Chemistry; metallurgy

Process for preparing 5-amino-2,3-dihydrophthalazine-1,4-dione monosodium salt

#2 | 2014-10-09 ✅ Patent 9,358,225 granted on 2016-06-07
US20140303212A1
Human necessities

Method for treating neurodegeneration using a p38MAPK inhibitor

#3 | 2014-01-30 ✅ Patent 9,968,602 granted on 2018-05-15
US20140030317A1
Human necessities

Modulation of cell fates and activities by phthalazinediones

#4 | 2010-10-07 ✅ Patent 8,895,555 granted on 2014-11-25
US20100255077A1
Human necessities

Methods of treating intestinal diseases and inflammatory conditions related to HIV-AIDS

#5 | 2010-09-02
US20100222584A1
Chemistry; metallurgy

PHARMACEUTICAL GRADE PHTHALAZINEDIONES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

#6 | 2010-04-08
US20100086531A1
Human necessities

METHODS OF MODULATING PROTEIN HOMEOSTASIS, METABOLIC SYNDROME, HEAVY METAL INTOXICATION AND Nrf2 TRANSCRIPTION FACTORS

#7 | 2009-02-05
US20090036411A1
Human necessities

MODULATION OF CELL FATES AND ACTIVITIES BY PHTHALAZINEDIONES

#8 | 2009-01-15 ✅ Patent 7,691,819 granted on 2010-04-06
US20090018137A1
Human necessities

Modulation of cell fates and activities by phthalazinediones

#9 | 2007-06-21
US20070142303A1
Human necessities

Modulation of cell fates and activities by phthalazinediones

#10 | 2005-12-29 ✅ Patent 7,326,690 granted on 2008-02-05
US20050288291A1
Human necessities

Modulation of cell fates and activities by phthalazinediones

#11 | 2005-10-11 ✅ Patent 6,953,799 granted on 2005-10-11
US10283647
-

Modulation of cell fates and activities by diketo phthalazines

Also check out Bach Pharma, Inc.'s (North Andover, United States) applicant profile with 3 patent applications submitted.

AssigneeID:

224713 ⎘